A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models.
Article in Immuno-Oncology Technology (September 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Immuno-Oncology Technology (September 2024)
Article in Expert Review of Molecular Diagnostics (February 2024)
Article in Investigational New Drugs (December 2023)